Literature DB >> 24526677

Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart.

Andrew N Carley1, Heinrich Taegtmeyer, E Douglas Lewandowski.   

Abstract

Metabolic signaling mechanisms are increasingly recognized to mediate the cellular response to alterations in workload demand, as a consequence of physiological and pathophysiological challenges. Thus, an understanding of the metabolic mechanisms coordinating activity in the cytosol with the energy-providing pathways in the mitochondrial matrix becomes critical for deepening our insights into the pathogenic changes that occur in the stressed cardiomyocyte. Processes that exchange both metabolic intermediates and cations between the cytosol and mitochondria enable transduction of dynamic changes in contractile state to the mitochondrial compartment of the cell. Disruption of such metabolic transduction pathways has severe consequences for the energetic support of contractile function in the heart and is implicated in the pathogenesis of heart failure. Deficiencies in metabolic reserve and impaired metabolic transduction in the cardiomyocyte can result from inherent deficiencies in metabolic phenotype or maladaptive changes in metabolic enzyme expression and regulation in the response to pathogenic stress. This review examines both current and emerging concepts of the functional linkage between the cytosol and the mitochondrial matrix with a specific focus on metabolic reserve and energetic efficiency. These principles of exchange and transport mechanisms across the mitochondrial membrane are reviewed for the failing heart from the perspectives of chronic pressure overload and diabetes mellitus.

Entities:  

Keywords:  cytosol; diabetes mellitus; heart failure; metabolic pathways; metabolism; mitochondria; mobilization

Mesh:

Year:  2014        PMID: 24526677      PMCID: PMC4410983          DOI: 10.1161/CIRCRESAHA.114.301863

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  147 in total

Review 1.  Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle.

Authors:  M J Gibala; M E Young; H Taegtmeyer
Journal:  Acta Physiol Scand       Date:  2000-04

2.  Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1.

Authors:  Iain Scott; Bradley R Webster; Jian H Li; Michael N Sack
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

Review 3.  Excitation-contraction coupling and mitochondrial energetics.

Authors:  Christoph Maack; Brian O'Rourke
Journal:  Basic Res Cardiol       Date:  2007-07-27       Impact factor: 17.165

4.  Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate.

Authors:  R R Russell; H Taegtmeyer
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

Review 5.  HDAC-dependent ventricular remodeling.

Authors:  Min Xie; Joseph A Hill
Journal:  Trends Cardiovasc Med       Date:  2013-03-15       Impact factor: 6.677

6.  Modulation of energy transfer pathways between mitochondria and myofibrils by changes in performance of perfused heart.

Authors:  Marko Vendelin; Jacqueline A Hoerter; Philippe Mateo; Sibylle Soboll; Brigitte Gillet; Jean-Luc Mazet
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

7.  Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Gene Kim; Madhu Gupta; Senthilkumar B Rajamohan; Jyothish B Pillai; Sadhana Samant; P V Ravindra; Ayman Isbatan; Mahesh P Gupta
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

8.  Identification of a novel malonyl-CoA IC(50) for CPT-I: implications for predicting in vivo fatty acid oxidation rates.

Authors:  Brennan K Smith; Christopher G R Perry; Timothy R Koves; David C Wright; Jeffrey C Smith; P Darrell Neufer; Deborah M Muoio; Graham P Holloway
Journal:  Biochem J       Date:  2012-11-15       Impact factor: 3.857

9.  Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport.

Authors:  L J Waber; D Valle; C Neill; S DiMauro; A Shug
Journal:  J Pediatr       Date:  1982-11       Impact factor: 4.406

10.  Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.

Authors:  O-J How; T S Larsen; A D Hafstad; A Khalid; E S P Myhre; A J Murray; N T Boardman; M Cole; K Clarke; D L Severson; E Aasum
Journal:  Arch Physiol Biochem       Date:  2007 Oct-Dec       Impact factor: 4.076

View more
  49 in total

1.  Multiphasic Regulation of Systemic and Peripheral Organ Metabolic Responses to Cardiac Hypertrophy.

Authors:  Chong Wee Liew; Shanshan Xu; Xuerong Wang; Maximilian McCann; Hyerim Whang Kong; Andrew C Carley; Jingbo Pang; Giamila Fantuzzi; J Michael O'Donnell; E Douglas Lewandowski
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

2.  "Sensing Danger": A New Player in the Innate Immune Response During Cardiac Pressure Overload.

Authors:  Andrew N Carley; E Douglas Lewandowski
Journal:  Circulation       Date:  2020-12-07       Impact factor: 29.690

3.  Comprehensive metabolic modeling of multiple 13C-isotopomer data sets to study metabolism in perfused working hearts.

Authors:  Scott B Crown; Joanne K Kelleher; Rosanne Rouf; Deborah M Muoio; Maciek R Antoniewicz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-08-05       Impact factor: 4.733

4.  Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice.

Authors:  Cong Wang; Fan Fan; Quan Cao; Cheng Shen; Hong Zhu; Peng Wang; Xiaona Zhao; Xiaolei Sun; Zhen Dong; Xin Ma; Xiangwei Liu; Shasha Han; Chaoneng Wu; Yunzeng Zou; Kai Hu; Junbo Ge; Aijun Sun
Journal:  J Mol Med (Berl)       Date:  2016-08-03       Impact factor: 4.599

5.  Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy.

Authors:  Andrea S Pereyra; Like Y Hasek; Kate L Harris; Alycia G Berman; Frederick W Damen; Craig J Goergen; Jessica M Ellis
Journal:  J Biol Chem       Date:  2017-09-15       Impact factor: 5.157

6.  Non-targeted metabolomics of Brg1/Brm double-mutant cardiomyocytes reveals a novel role for SWI/SNF complexes in metabolic homeostasis.

Authors:  Ranjan Banerjee; Scott J Bultman; Darcy Holley; Carolyn Hillhouse; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Monte S Willis
Journal:  Metabolomics       Date:  2015-10-01       Impact factor: 4.290

7.  Peroxisome proliferator-activated receptor-α expression induces alterations in cardiac myofilaments in a pressure-overload model of hypertrophy.

Authors:  Chehade N Karam; Chad M Warren; Marcus Henze; Natasha H Banke; E Douglas Lewandowski; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-27       Impact factor: 4.733

8.  Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.

Authors:  Emirhan Nemutlu; Song Zhang; Yi-Zhou Xu; Andre Terzic; Li Zhong; Petras D Dzeja; Yong-Mei Cha
Journal:  J Card Fail       Date:  2015-04-22       Impact factor: 5.712

9.  Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.

Authors:  Joseph R Goldenberg; Xuerong Wang; E Douglas Lewandowski
Journal:  J Mol Cell Cardiol       Date:  2016-03-16       Impact factor: 5.000

10.  Mitochondrial protein hyperacetylation in the failing heart.

Authors:  Julie L Horton; Ola J Martin; Ling Lai; Nicholas M Riley; Alicia L Richards; Rick B Vega; Teresa C Leone; David J Pagliarini; Deborah M Muoio; Kenneth C Bedi; Kenneth B Margulies; Joshua J Coon; Daniel P Kelly
Journal:  JCI Insight       Date:  2016-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.